Retinal nerve fiber layer and future risk of multiple sclerosis

Canadian Journal of Neurological Sciences

Volumn 35, Issue 4, 2008, Pages 482-487

  Costello, Fiona ^a,b,e   Hodge, William ^c   Pan, Y Irene ^c   Metz, Luanne ^a   Kardon, Randy H ^d  

^a UNIVERSITY OF CALGARY   (Canada)

^b Department of Ophthalmology ^*  (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d UNIVERSITY OF IOWA   (United States)

^e Rockyview Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; OPTIC NERVE FIBER; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT DISEASE; RETINAL NERVE FIBER LAYER; RISK FACTOR; THICKNESS; VISION; VISUAL ACUITY; VISUAL FIELD;

EID: 55049141215     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S031716710000915X     Document Type: Article

References (27)

1. Hickman SJ, Dalton CM, Miller DH, Plant GT. Management of acute optic neuritis. Lancet. 2002; 360 (9349): 1953-62.
2. Miller D, Barkhof F, Montalban X, Thompson A, Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol. 2005; 4 (5): 281-8.
3. Beck RW, Cleary PA, Anderson MM Jr, Keltner JL, Shults WT, Kaufman DI, et al. Optic Neuritis Study Group. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med. 1992; 326 (9): 581-8.
4. Optic Neuritis Study Group. The 5-year risk of MS after optic neuritis. Experience of the Optic Neuritis Treatment Trial. Neurology. 1997; 49 (5): 1404-13.
5. Beck RW, Trobe JD, Moke PS, Gal RL, Xing D, Bhatti MT, et al. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol. 2003; 121 (7): 944-9.
6. Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med. 2000; 343 (13): 898-904.
7. Comi G, Filippi M, Barkhof F, Durelli L, Edan G, Fernandez O, et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet. 2001; 357 (9268): 1576-82.
8. Kappos L, Polman CH, Freedman MS, Edan G, Hartung HP, Miller DH, et al. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology. 2006; 67(7): 1242-9.
9. Parisi V, Manni G, Spadaro M, Colacino G, Restuccia R, Marchi S, et al. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci. 1999; 40 (11): 2520-7.
10. Trip SA, Schlottmann PG, Jones SJ, Altmann DR, Garway - Heath DF, Thompson AJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol. 2005; 58 (3): 383-91.
11. Fisher JB, Jacobs DA, Markowitz CE, Galetta SL, Volpe NJ, Nano - Schiavi ML, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 2006; 113 (2): 324-32.
12. Noval S, Contreras I, Rebolleda G, Munoz-Negrete FJ. Optical coherence tomography versus automated perimetry for follow-up of optic neuritis. Acta Ophthalmol Scand. 2006; 84 (6): 790-4.
13. Costello F, Coupland S, Hodge W, Lorello GR, Koroluk J, Pan YI, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol. 2006; 59 (6): 963-9.
14. Trip SA, Schlottmann PG, Jones SJ, Li WY, Garway - Heath DF, Thompson AJ, et al. Optic nerve atrophy and retinal nerve fiber layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage. 2006; 31 (1): 286-93.
15. Trip SA, Schlottmann PG, Jones SJ, Li WY, Garway - Heath DF, Thompson AJ, et al. Optic nerve magnetization transfer imaging and measures of axonal loss and demyelination in optic neuritis. Mult Scler. 2007; (7): 875-9.
16. Sepulcre J, Murie - Fernandez M, Salinas - Alaman A, Garcia - Layana A, Bejarano B, Villoslada P. Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology. 2007; 68 (18): 1488-94.
17. Gordon - Lipkin E, Chodkowski B, Reich DS, Smith SA, Pulicken M, Balcer LJ, et al. Retinal nerve fiber layer associated with brain atrophy in multiple sclerosis. Neurology. 2007; 69 (16): 1603-9.
18. Pulicken M, Gordon - Lipkin E, Balcer LJ, Frohman E, Cutter G, Calabresi PA, et al. Optical coherence tomography and disease subtype in multiple sclerosis. Neurology. 2007; 69 (22): 2085-92.
19. Henderson AP, Trip SA, Schlottmann PG, Altmann DR, Garway - Heath DF, Plant GT, et al. An investigation of the retinal nerve fiber layer in progressive multiple sclerosis using optical coherence tomography. Brain. 2008; 131: 277-87.
20. Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, et al. Optical coherence tomography. Science. 1991; 254 (5035):1178-81.
21. Baumal CR. Clinical applications of optical coherence tomography. Curr Opin Ophthalmol. 1999; 10 (3): 182-8.
22. Paunescu LA, Schuman JS, Price LL, Stark PC, Beaton S, Ishikawa H, et al. Reproducibility of nerve fiber thickness, macular thickness and optic nerve head measurements using Stratus OCT. Invest Ophthalmol Vis Sci. 2004; 45 (6):1716-24.
23. Schuman JS, Hee MR, Puliafito CA, Wong C, Pedut - Kloizman T, Lin CP, et al. Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography a pilot study. Arch Ophthalmol. 1995;113 (5): 586-96.
24. Frisen LF, Hoyt WF. Insidious atrophy of retinal nerve fibers in multiple sclerosis. Arch Ophthalmol. 1974; 92 (2):91-7.
25. Poser CM, Paty DW, Sheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983; 13 (3): 227-31.
26. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for Multiple Sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol. 2005; 58 (6): 840-6.
27. Ferris FL III, Kassoff A, Bresnick GH, Bailey L. New visual acuity charts for clinical research. Am J Ophthalmol. 1982; 94 (1): 91-6.